Since the goal was to identify a prognostic biomarker that could predict 2-year MALEs in patients with PAD, IL-7 was deemed to be a more suitable candidate as a PAD prognostic biomarker given its strong association with 2-year MALEs (HR 1.56 [95% CI 1.12–1.88]). Here, IL7 is linked to peripheral arterial disease.